Menu Close

Continuing Medical Education (CME)

2024 CME Information

3.75 Credits Available

1.25 CME Credits

May 30th, 2024, 9:30-10:45 am (EST)

“Cannabis, Endocannabinoids and PTSD”

– Dr. Matthew Hill

1.25 CME Credits

May 30th, 2024, 1:00-2:15 pm (EST)

“Using Laboratory Science to Inform Clinical Decision Making and Patient Safety in Medicinal Cannabis”

– Dr. Ryan Vandrey

1.25 CME Credits

May 31st, 2024, 8:15-9:30 am (EST)

 “Cannabis Use Disorder”

– Dr. Margaret Haney

  • Learning objectives: As a result of participation in this activity, participants will be able to learn about:
    • Learn about using laboratory science to inform clinical decision making for patient safety in medicinal cannabis 
    • Learn about how cannabis effects the endocannabinoid system with particular focus on PTSD 
    • Learn about sex differences in symptoms of Cannabis Use Disorder
  • Target audience: Primary care physicians and specialty physicians
  • Accreditation statement: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • Credit statement: The University of Florida College of Medicine designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • Commercial support (grant/exhibit) acknowledgement:
    • This conference is supported by:
    • Exhibits: FAMU Medical Marijuana Education and Research Initiative and OMMU (Office of Medical Marijuana Use)
    • Grants: None
  • Disclosure statement: No one in a position to control content has any financial relationships to disclose. Conflict of interest information for the CME Advisory Committee members can be found on the following website: All relevant financial relationships have been mitigated.